Telmisartan to Reduce AIDS-Related Fibrotic and Inflammatory Contributors (TRAFIC Study)

Clinical trial NCT01928927 · COMPLETED

Trial details

NCT number: NCT01928927
Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

HIV-1 Infection

Start date: 2014-01-01
Primary completion: 2016-03-01
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.